Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series

Negligible influence of moderate to severe hyperthermia on blood-brain barrier permeability and neuronal-parenchymal integrity in healthy men

(2021) Brooke R. Shepley et al.   JOURNAL OF APPLIED PHYSIOLOGY

BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases

(2020) Miriana d’Alessandro et al.   CLINICAL AND EXPERIMENTAL MEDICINE

The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients

(2020) Paolo Cameli et al.   RESPIRATION

Serum KL‐6 levels in pulmonary Langerhans’ cell histiocytosis

(2020) Miriana d’Alessandro et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review

(2020) Miriana d’Alessandro et al.   Biomarkers in Medicine

Utility of serological biomarker’ panels for diagnostic accuracy of interstitial lung diseases

(2020) Laura Bergantini et al.   IMMUNOLOGIC RESEARCH

Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression

(2020) Carmel J.W. Stock et al.   RESPIROLOGY

NK and NKT-like cells in granulomatous and fibrotic lung diseases

(2019) L Bergantini et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

(2018) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study

(2017) Toby M Maher et al.   Lancet Respiratory Medicine

The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis

(2017) Shoichiro Ohta et al.   PLoS One

Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias

(2016) Eric S. White et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients

(2015) Yang Hu et al.   Clinical Respiratory Journal

A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls

(2014) Claudia Landi et al.   Proteomics Clinical Applications

Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers

(2014) Huaping Dai et al.   RESPIROLOGY

Serum Analysis of Coagulation Factors in IPF and NSIP

(2013) E. Bargagli et al.   INFLAMMATION

Human Chitotriosidase: a Sensitive Biomarker of Sarcoidosis

(2012) Elena Bargagli et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis

(2012) AHMED FAHIM et al.   RESPIROLOGY

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges

(2012) Paolo Spagnolo et al.   MULTIDISCIPLINARY RESPIRATORY MEDICINE

The Significance of Elevated Tumor Markers Among Patients With Idiopathic Pulmonary Fibrosis Before and After Lung Transplantation

(2011) Victoria Rusanov et al.   CHEST

Integrating mechanisms of pulmonary fibrosis

(2011) Thomas A. Wynn   JOURNAL OF EXPERIMENTAL MEDICINE

Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis

(2009) E. Bargagli et al.   RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY

Human Chitotriosidase: A Potential New Marker of Sarcoidosis Severity

(2008) Elena Bargagli et al.   RESPIRATION

Chitotriosidase and soluble IL‐2 receptor: Comparison of two markers of sarcoidosis severity

(2008) Elena Bargagli et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis

(2008) Ivan O Rosas et al.   PLOS MEDICINE